Find out everything you need to know about the latest COVID-19 booster shot here >

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Investigator: Bincy Abraham, MD

Study Coordinator: Mayyadah Al-Sabbagh

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT01848561

Phone: 346.238.0307

Protocol Number: Pro00011106

Description

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
More to Explore
Search Clinical Trials
Join a Clinical Trial
Clinical Research Support Services for Investigators
Weill Cornell Medical College Clinical Trials